Control of Mosquito-Borne Diseases: Discovery of a New Genetic Element in the Wolbachia Bacterium

Article

Researchers from INRA, CIRAD, CEA, the University of Montpellier, and Chicago and Vanderbilt Universities have developed an innovative method for analyzing the genome of the Wolbachia bacterium. This endosymbiotic bacterium infects more than 70 percent of insects and is capable of influencing insect transmission of pathogens such as dengue or Zika virus. By sequencing and studying all DNA present in the ovaries of Culex pipiens mosquitoes, the researchers identified for the first time a novel mobile genetic element in this bacterium. This discovery opens up new research avenues to better understand interactions between the Wolbachia bacterium and its host mosquito, as well as its role in pathogen transmission. This research, published in Nature Communications , provides opportunities for the biological control of insect-borne pathogens, a major public health challenge.

The incidence of diseases and the risks associated with pathogens transmitted by mosquitoes, such as the parasite Plasmodium faliciparum (an agent of malaria) and viruses including dengue, Zika, chikungunya, West Nile and Rift Valley fever, are growing throughout the world. The use of insecticides is the most common method for controlling mosquito populations, but resistance to the different types of pesticides currently in use is widespread. In this context, new tools to control pathogen transmission in natural populations of mosquitoes based on the use of their bacteria, such as Wolbachia , are being developed worldwide.

Wolbachia is capable of altering their reproduction and reducing the transmission of pathogens in numerous species of mosquito (for example Aedes aegypti and Anopheles gambiae ). It is currently used in a number of major biological vector control programmes, such as the global program "Eliminate Dengue." However, the molecular mechanisms involved in interactions between Wolbachia , the insect and the pathogen are still poorly understood.

With the goal of better understanding the role of the endosymbiotic bacterium in the transmission of pathogens and dissecting the underlying molecular mechanisms, an international team of scientists from INRA, CIRAD, CEA, and the Universities of Montpellier, Chicago and Vanderbilt conducted metagenomic**analyses of mosquitoes in order to reconstruct the genomes of the Wolbachia bacterium through an innovative approach. For the first time, they obtained sequences of Wolbachia from the ovaries of Culex pipiens captured in France, working with individual mosquitoes rather than with pools, as is the case with conventional methods. This new approach identified novel aspects of the genome of the endosymbiotic bacterium Wolbachia and of its mobile genetic elements.

The analyses conducted using short- and long-read sequencing data identified an extrachromosomal circular piece of DNA, previously unknown in Wolbachia , called pWCP (Plasmid of Wolbachia in Culex pipiens ). This circular DNA has 14 genes and appears to be present in several copies in the bacterium, in addition to its chromosome. Searching for pWCP in previously published data confirmed its presence on a broader scale in specimens of Culex pipiens collected in North Africa.

The discovery of this plasmid DNA in Wolbachia thanks to innovative metagenomics approaches will enable investigation of the development of a new genetic engineering tool for this bacterium. This discovery could provide new generic knowledge of the mechanisms involved in interactions between the bacterium, the insect and the pathogens it transmits, and more specifically of the mechanisms through which the bacterium regulates the transmission of these pathogens. This knowledge would have direct applications for biological control of the insect vectors of pathogens responsible for some major animal and human diseases.

Source: CIRAD

Related Videos
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Related Content